Phibro Animal Health draws on credit facilities to buy Osprey business

By Wendy Van Sickle

Columbus, Ohio, Aug. 1 – Phibro Animal Health Corp. drew down on its existing credit facilities to fund its acquisition of the business and assets of Osprey Biotechnics, Inc., according to a news release.

Osprey is a privately held developer and marketer of microbial products.

Phibro expects the transaction to be accretive to adjusted EBITDA and adjusted diluted earnings per share for the fiscal year ending June 30, 2020.

Phibro is a Teaneck, N.J.-based animal health and mineral nutrition company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.